Condition
Hypertension, Pulmonary Arterial
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01501838RecruitingPrimary
Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires
NCT07039604Recruiting
Real-World Study of PADN for the Treatment of PAH
NCT04663217Completed
Exercise Hemodynamic, Right Ventricular Coupling and Echocardiography in Pulmonary Hypertension
NCT05029167Not ApplicableUnknownPrimary
REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest (RELIEPH-study)
Showing all 4 trials